Cardiothoracic Surgery
MD, Chief, Division of Thoracic Surgery; Chief, Section of Esophageal Surgery; Director, Center of Esophageal Cancer. Zhong Shan Hospital, Shanghai Medical College, Fu Dan University, China
Selected publications from PubMed
The association between documented right ventricular dysfunction and in-hospital mortality in mechanically ventilated critically ill patients receiving a noradrenaline infusion: A retrospective observational cohort study.
Tan LH, Paul E, Simpson A, Marasco S, Orde S, Hare J, Udy A
Crit Care Resusc. 2026 Sep;28(3):100210 doi: 10.1016/j.ccrj.2026.100210.
Loss of ATP-Dependent Citrate Lyase Drives Left Ventricular Dysfunction by Metabolic Remodeling.
Liu S, Gammon ST, Tan L, Gao Y, Kim K, Elbatreek MH, Arrieta A, Williamson IK, Salazar RL, Pham J, Davidian A, Khanna Neicheril R, Gould BD, Vitrac H, Sadiq A, Dinh AQ, Lien EC, de Luna Vitorino FN, Gongora JM, Martinez SA, Odenkirk MT, Boatman AK, Chappel JR, Czer LSC, Kransdorf EP, Lefer DJ, Hanson BM, Garcia BA, Baker EM, Vander Heiden MG, Lorenzi PL, Taegtmeyer H, Piwnica-Worms D, Martin JF, Karlstaedt A
Circulation. 2026 Jul 21;154(3):223-239 doi: 10.1161/CIRCULATIONAHA.125.076453.
Pathologic complete response after neoadjuvant immunochemotherapy: Persistent recurrence risk highlights the need for stratified management.
Yuan C, Chen C, Liu Z, Tan L, Li Y, Tian Z, Chen Y, Ma J, Liu S, Chen C, Han Y, Chen L, Yu B, Jiang T, Li X, Wang W, Wei L, Chen Q, Zhao J, Fu J, Tian H, Ma Y, Yi J, Hu W, Zhang G, Lian J, Mei X, Chen K, Mao Y, Li Z, Esophageal Cancer Committee of Chinese Anti-Cancer Association (CACA)
J Thorac Cardiovasc Surg. 2026 Jul;172(1):32-42.e8 doi: 10.1016/j.jtcvs.2026.02.017.
Epigenetic silencing of TBX1 inactivates the Hippo pathway to potentiate chemoresistance in esophageal squamous cell carcinoma.
Xu Z, Ma G, Shen Y, Tan L, Sun X, Peng L, Peng W, Ye L
Cell Death Dis. 2026 Jun 9;17(1) doi: 10.1038/s41419-026-08934-4.
Robot-assisted versus conventional minimally invasive oesophagectomy for oesophageal squamous cell carcinoma (RAMIE): a multicentre, open-label, randomised, phase 3, non-inferiority trial.
Yang Y, Liu Z, Li C, Li B, Yu B, Yi J, Zhang X, Chen H, Li H, Tan L, Hua R, Guo X, Yang X, Ma W, Sun Y, Li Z, RAMIE study group
Lancet Gastroenterol Hepatol. 2026 Jun;11(6):452-462 doi: 10.1016/S2468-1253(25)00402-9.
Help your network discover Dr. Lijie Tan's clinical expertise.
